Semin intervent Radiol 2017; 34(04): 398-408
DOI: 10.1055/s-0037-1608863
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Malignant Venous Obstruction: Superior Vena Cava Syndrome and Beyond

Tamir Friedman
1   Department of Radiology, Division of Interventional Radiology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York
,
Keith B. Quencer
2   Department of Radiology, Division of Interventional Radiology, University of Utah School of Medicine, Salt Lake City, Utah
,
Sirish A. Kishore
1   Department of Radiology, Division of Interventional Radiology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York
,
Ronald S. Winokur
1   Department of Radiology, Division of Interventional Radiology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York
,
David C. Madoff
1   Department of Radiology, Division of Interventional Radiology, New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
14. Dezember 2017 (online)

Abstract

Venous obstruction in the cancer population can result in substantial morbidity and, in extreme cases, mortality. While venous obstruction can be caused by both benign and malignant etiologies in this population, the management of malignant venous obstruction as a palliative measure can be somewhat nuanced with respect to nonprocedural and procedural management, both with respect to treatment of the underlying malignancy as well as treatment of venous hypertension, which may be associated with venous thrombosis. Symptom severity, primary malignancy, functional status, and prognosis are all fundamental to the patient workup and dictate both the timing and extent of endovascular intervention. The morbidity and mortality associated with malignant obstructions of central venous structures, specifically the superior vena cava and inferior vena cava, can be significantly improved with endovascular management in appropriately selected patients. Thus, the pertinent literature regarding the clinical presentation, workup, and endovascular management of malignant central venous obstruction syndromes, with directed attention to superior vena cava syndrome and inferior vena cava syndrome, will be reviewed in this article.

 
  • References

  • 1 Wilson LD, Detterbeck FC, Yahalom J. Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med 2007; 356 (18) 1862-1869
  • 2 Zisis C, Skevis K, Kefaloyannis EM, Avgoustou K, Bellenis I. Mediastinal tuberculous lymphadenitis presenting as superior vena cava syndrome. J Thorac Cardiovasc Surg 2006; 131 (06) e11-e12
  • 3 Bandyopadhyay SK, Sarkar N, Ghosh S, Dasgupta S. Tubercular mediastinal lymphadenopathy presenting as superior vena cava syndrome. J Assoc Physicians India 2002; 50 (Sep): 1194-1195
  • 4 Phillips PL, Amberson JB, Libby DM. Syphilitic aortic aneurysm presenting with the superior vena cava syndrome. Am J Med 1981; 71 (01) 171-173
  • 5 Kee ST, Kinoshita L, Razavi MK, Nyman UR, Semba CP, Dake MD. Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology 1998; 206 (01) 187-193
  • 6 Stevens DC, Butty S, Johnson MS. Superior vena cava rupture and cardiac tamponade complicating the endovascular treatment of malignant superior vena cava syndrome: a case report and literature review. Semin Intervent Radiol 2015; 32 (04) 439-444
  • 7 Rice TW, Rodriguez RM, Light RW. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore) 2006; 85 (01) 37-42
  • 8 Urban T, Lebeau B, Chastang C, Leclerc P, Botto MJ, Sauvaget J. Superior vena cava syndrome in small-cell lung cancer. Arch Intern Med 1993; 153 (03) 384-387
  • 9 Straka C, Ying J, Kong F-M, Willey CD, Kaminski J, Kim DW. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus 2016; 5 (01) 229
  • 10 Kapur S, Paik E, Rezaei A, Vu DN. Where there is blood, there is a way: unusual collateral vessels in superior and inferior vena cava obstruction. Radiographics 2010; 30 (01) 67-78
  • 11 Eren S, Karaman A, Okur A. The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT. Eur J Radiol 2006; 59 (01) 93-103
  • 12 Yoshimitsu K, Honda H, Kuroiwa T. , et al. Unusual hemodynamics and pseudolesions of the noncirrhotic liver at CT. Radiographics 2001; 21 (Spec No): S81-S96
  • 13 Virmani V, Lal A, Ahuja CK, Khandelwal N. The CT Quadrate lobe hot spot sign. Ann Hepatol 2010; 9 (03) 296-298
  • 14 Dickson AM. The focal hepatic hot spot sign. Radiology 2005; 237 (02) 647-648
  • 15 Wan JF, Bezjak A. Superior vena cava syndrome. Emerg Med Clin North Am 2009; 27 (02) 243-255
  • 16 Lepper PM, Ott SR, Hoppe H. , et al. Superior vena cava syndrome in thoracic malignancies. Respir Care 2011; 56 (05) 653-666
  • 17 Lonardi F, Gioga G, Agus G, Coeli M, Campostrini F. Double-flash, large-fraction radiation therapy as palliative treatment of malignant superior vena cava syndrome in the elderly. Support Care Cancer 2002; 10 (02) 156-160
  • 18 Rodrigues CI, Njo KH, Karim AB. Hypofractionated radiation therapy in the treatment of superior vena cava syndrome. Lung Cancer 1993; 10 (3-4): 221-228
  • 19 Nicholson AA, Ettles DF, Arnold A, Greenstone M, Dyet JF. Treatment of malignant superior vena cava obstruction: metal stents or radiation therapy. J Vasc Interv Radiol 1997; 8 (05) 781-788
  • 20 Wilson E, Lyn E, Lynn A, Khan S. Radiological stenting provides effective palliation in malignant central venous obstruction. Clin Oncol (R Coll Radiol) 2002; 14 (03) 228-232
  • 21 Sato Y, Inaba Y, Yamaura H, Takaki H, Arai Y. Malignant inferior vena cava syndrome and congestive hepatic failure treated by venous stent placement. J Vasc Interv Radiol 2012; 23 (10) 1377-1380
  • 22 Mose S, Stabik C, Eberlein K, Ramm U, Böttcher HD, Budischewski K. Retrospective analysis of the superior vena cava syndrome in irradiated cancer patients. Anticancer Res 2006; 26 (6C): 4933-4936
  • 23 Van Putten JW, Schlosser NJ, Vujaskovic Z, Leest AH, Groen HJ. Superior vena cava obstruction caused by radiation induced venous fibrosis. Thorax 2000; 55 (03) 245-246
  • 24 Lanciego C, Pangua C, Chacón JI. , et al. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. AJR Am J Roentgenol 2009; 193 (02) 549-558
  • 25 Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol) 2002; 14 (05) 338-351
  • 26 Lee-Elliott CE, Abubacker MZ, Lopez AJ. Fast-track management of malignant superior vena cava syndrome. Cardiovasc Intervent Radiol 2004; 27 (05) 470-473
  • 27 Fagedet D, Thony F, Timsit JF. , et al. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol 2013; 36 (01) 140-149
  • 28 Ganeshan A, Hon LQ, Warakaulle DR, Morgan R, Uberoi R. Superior vena caval stenting for SVC obstruction: current status. Eur J Radiol 2009; 71 (02) 343-349
  • 29 Büstgens FA, Loose R, Ficker JH, Wucherer M, Uder M, Adamus R. Stent implantation for superior vena cava syndrome of malignant cause. RoFo Fortschr Geb Rontgenstr Nuklearmed 2017; 189 (05) 423-430
  • 30 Gwon DI, Ko GY, Kim JH, Shin JH, Yoon HK, Sung KB. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents. Radiology 2013; 266 (03) 979-987
  • 31 Rachapalli V, Boucher LM. Superior vena cava syndrome: role of the interventionalist. Can Assoc Radiol J 2014; 65 (02) 168-176
  • 32 Gray BH, Olin JW, Graor RA, Young JR, Bartholomew JR, Ruschhaupt WF. Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chest 1991; 99 (01) 54-59
  • 33 Uberoi R. Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Intervent Radiol 2006; 29 (03) 319-322
  • 34 Dinkel HP, Mettke B, Schmid F, Baumgartner I, Triller J, Do DD. Endovascular treatment of malignant superior vena cava syndrome: is bilateral Wallstent placement superior to unilateral placement?. J Endovasc Ther 2003; 10 (04) 788-797
  • 35 Choe YH, Im JG, Park JH, Han MC, Kim CW. The anatomy of the pericardial space: a study in cadavers and patients. AJR Am J Roentgenol 1987; 149 (04) 693-697
  • 36 Nagata T, Makutani S, Uchida H. , et al. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava. Cardiovasc Intervent Radiol 2007; 30 (05) 959-967
  • 37 Martin M, Baumgartner I, Kolb M, Triller J, Dinkel H-P. Fatal pericardial tamponade after Wallstent implantation for malignant superior vena cava syndrome. J Endovasc Ther 2002; 9 (05) 680-684
  • 38 Entwisle KG, Watkinson AF, Reidy J. Case report: migration and shortening of a self-expanding metallic stent complicating the treatment of malignant superior vena cava stenosis. Clin Radiol 1996; 51 (08) 593-595
  • 39 Fajardo LF, Lee A. Rupture of major vessels after radiation. Cancer 1975; 36 (03) 904-913
  • 40 Zidar N, Ferluga D, Hvala A, Popović M, Šoba E. Contribution to the pathogenesis of radiation-induced injury to large arteries. J Laryngol Otol 1997; 111 (10) 988-990
  • 41 Cui J, Kawai T, Irani Z. Catheter-directed thrombolysis in acute superior vena cava syndrome caused by central venous catheters. Semin Dialysis 2015; 28 (05) 548-551
  • 42 Abdullah BJ, Mohammad N, Sangkar JV. , et al. Incidence of upper limb venous thrombosis associated with peripherally inserted central catheters (PICC). Br J Radiol 2005; 78 (931) 596-600
  • 43 Clark K, Chick JF, Reddy SN. , et al. Concurrent central venous stent and central venous access device placement does not compromise stent patency or catheter function in patients with malignant central venous obstruction. J Vasc Interv Radiol 2017; 28 (04) 602-607
  • 44 Kandpal H, Sharma R, Gamangatti S, Srivastava DN, Vashisht S. Imaging the inferior vena cava: a road less traveled. Radiographics 2008; 28 (03) 669-689
  • 45 Kaufman LB, Yeh BM, Breiman RS, Joe BN, Qayyum A, Coakley FV. Inferior vena cava filling defects on CT and MRI. AJR Am J Roentgenol 2005; 185 (03) 717-726
  • 46 Sauter A, Triller J, Schmidt F, Kickuth R. Treatment of superior vena cava (SVC) syndrome and inferior vena cava (IVC) thrombosis in a patient with colorectal cancer: combination of SVC stenting and IVC filter placement to palliate symptoms and pave the way for port implantation. Cardiovasc Intervent Radiol 2008; 31 (02) (Suppl. 02) S144-S148
  • 47 Fletcher WS, Lakin PC, Pommier RF, Wilmarth T. Results of treatment of inferior vena cava syndrome with expandable metallic stents. Arch Surg 1998; 133 (09) 935-938
  • 48 Labropoulos N, Borge M, Pierce K, Pappas PJ. Criteria for defining significant central vein stenosis with duplex ultrasound. J Vasc Surg 2007; 46 (01) 101-107
  • 49 Devcic Z, Techasith T, Banerjee A, Rosenberg JK, Sze DY. Technical and anatomic factors influencing the success of inferior vena caval stent placement for malignant obstruction. J Vasc Interv Radiol 2016; 27 (09) 1350-1360.e1
  • 50 Jeong HJ, Seo IY, Rim JS. Chronic post-thrombotic obstruction of the inferior vena cava: both renal veins being the cause of painless gross hematuria from pelviureteral mucosal varices in normal functioning kidney. Yonsei Med J 2003; 44 (06) 1119-1121
  • 51 Gordon S, Kerns T, Londeree W, Ching B. Idiopathic thrombosis of the inferior vena cava and bilateral femoral veins in an otherwise healthy male soldier. Case Rep Med 2013; 2013: 246201
  • 52 Shin N, Kim YH, Xu H. , et al. Redefining Budd-Chiari syndrome: a systematic review. World J Hepatol 2016; 8 (16) 691-702
  • 53 Goto H, Hashimoto M, Akamatsu D. , et al. Surgical resection and inferior vena cava reconstruction for treatment of the malignant tumor: technical success and outcomes. Ann Vasc Dis 2014; 7 (02) 120-126
  • 54 Quinones-Baldrich W, Alktaifi A, Eilber F, Eilber F. Inferior vena cava resection and reconstruction for retroperitoneal tumor excision. J Vasc Surg 2012; 55 (05) 1386-1393 , discussion 1393
  • 55 Brountzos EN, Binkert CA, Panagiotou IE, Petersen BD, Timmermans H, Lakin PC. Clinical outcome after intrahepatic venous stent placement for malignant inferior vena cava syndrome. Cardiovasc Intervent Radiol 2004; 27 (02) 129-136
  • 56 Razavi MK, Hansch EC, Kee ST, Sze DY, Semba CP, Dake MD. Chronically occluded inferior venae cavae: endovascular treatment. Radiology 2000; 214 (01) 133-138
  • 57 Wallace MJ. Transatrial stent placement for treatment of inferior vena cava obstruction secondary to extension of intracardiac tumor thrombus from hepatocellular carcinoma. J Vasc Interv Radiol 2003; 14 (10) 1339-1343
  • 58 Barquero-Romero J, López Cupido V, Torrado Sierra O, Valencia Terrón M. Severe ocular symptoms as an initial manifestation of superior vena cava syndrome [in Spanish]. Med Interna 2008; 25 (07) 356-358